Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
ResMed Inc.

ResMed Inc. (RMD) Stock Overview

Explore ResMed Inc.’s financial performance, market position, analyst ratings, and future outlook.

RMD●NYSE
HealthcareMedical - Devices
$195.27
$3.38(1.76%)
U.S. Market opens in 63h 27m

ResMed Inc. (RMD)

Meyka AI Score

Z

Key Financials

Market Cap28.3B
P/E Ratio18.92
EPS (TTM)$10.77
ROE0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$240.15
3 Months$239.43
1 Year Target$225.06

RMD Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of ResMed Inc. (NYSE: RMD) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, ResMed Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of RMD on the NYSE shows an RSI of 46.65, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $225.06 for the NYSE listing.

Key metrics behind ResMed Inc.'s NYSE-traded stock include a P/E ratio of 18.92 and a market capitalization of 28.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of RMD on the NYSE.

Price Performance (NYSE: RMD)

1-Day Change
1.79%
5-Day Change
-2.92%
1-Month Change
-0.60%
3-Month Change
-11.16%
6-Month Change
-22.61%
Year-to-Date (YTD) Change
-18.91%
1-Year Change
-28.59%
3-Year Change
-10.47%
5-Year Change
-24.80%
All-Time (Max) Change
28970.67%

Contact Information

https://www.resmed.com
858 836 5000
9001 Spectrum Center Boulevard, San Diego, CA, 92123

Company Facts

106,000 Employees
IPO DateJun 2, 1995
CountryUS
Actively Trading

Frequently Asked Questions